BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20558980)

  • 1. Outcomes of radical prostatectomy in clinically locally advanced N0M0 prostate cancer.
    Mearini L; Zucchi A; Costantini E; Bini V; Nunzi E; Porena M
    Urol Int; 2010; 85(2):166-72. PubMed ID: 20558980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of adjuvant radiotherapy after radical prostatectomy for prostate cancer patients.
    Suzuki K; Nakano K; Morita T
    Urol Int; 2010; 84(4):382-7. PubMed ID: 20224263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.
    Boorjian SA; Thompson RH; Tollefson MK; Rangel LJ; Bergstralh EJ; Blute ML; Karnes RJ
    Eur Urol; 2011 Jun; 59(6):893-9. PubMed ID: 21388736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.
    Masieri L; Lanciotti M; Nesi G; Lanzi F; Tosi N; Minervini A; Lapini A; Carini M; Serni S
    Urol Int; 2010; 85(4):396-400. PubMed ID: 20516669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for and outcome of locally advanced prostate cancer after radical prostatectomy.
    Hsu CY; Wildhagen MF; Van Poppel H; Bangma CH
    BJU Int; 2010 Jun; 105(11):1536-40. PubMed ID: 19912180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
    Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
    J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
    Menon M; Bhandari M; Gupta N; Lane Z; Peabody JO; Rogers CG; Sammon J; Siddiqui SA; Diaz M
    Eur Urol; 2010 Dec; 58(6):838-46. PubMed ID: 20869162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
    Lughezzani G; Budäus L; Isbarn H; Sun M; Perrotte P; Haese A; Chun FK; Schlomm T; Steuber T; Heinzer H; Huland H; Montorsi F; Graefen M; Karakiewicz PI
    Eur Urol; 2010 Apr; 57(4):562-8. PubMed ID: 20018437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment].
    Rosas-Nava JE; Herranz-Amo F; Paños-Fagundo EV; Lledó-García E; Verdú-Tartajo F; Hernández-Fernández C
    Actas Urol Esp; 2011 May; 35(5):272-6. PubMed ID: 21397985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.
    Abdollah F; Suardi N; Cozzarini C; Gallina A; Capitanio U; Bianchi M; Sun M; Fossati N; Passoni NM; Fiorino C; Di Muzio N; Karakiewicz PI; Rigatti P; Montorsi F; Briganti A
    Eur Urol; 2013 Jun; 63(6):998-1008. PubMed ID: 23122664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis.
    Briganti A; Karnes RJ; Da Pozzo LF; Cozzarini C; Capitanio U; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Di Muzio N; Rigatti P; Montorsi F; Blute M
    Eur Urol; 2011 May; 59(5):832-40. PubMed ID: 21354694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.